A trial of Ro 4-2137 in the treatment of hypertension.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure; D004232:Diuretics / Q000627:therapeutic use; D004357:Drug Synergism; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use*; D012694:Serine / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014443:Tyrosine / Q000031:analogs & derivatives
D000959:Antihypertensive Agents; D004232:Diuretics; D008738:Methyl Ethers; D010636:Phenols; C001653:DL-(4-hydroxy-3-methoxyphenyl)serine; D014443:Tyrosine; D012694:Serine